
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc. anticipates significant growth in its net PLGL liability, projected to increase from $78 million at year-end 2024 to between $145 million and $165 million by the end of 2025, indicative of robust operational positioning. The company continues to benefit from a strong demand for behavioral health services, leveraging organic growth opportunities through bed expansions and new facility developments, while maintaining strong capitalization for potential mergers and acquisitions. Additionally, guidance suggests an expected improvement in organic earnings growth, pointing to a favorable outlook for the company amid rising claims activity and strategic operational enhancements.
Bears say
Acadia Healthcare Co Inc has experienced a series of downward revisions in its financial guidance, with EBITDA projections for 2025 reduced by approximately 13.4% to a new range of $601-611 million largely due to higher-than-expected PLGL expenses. The company anticipates that these elevated expenses will persist into 2026, leading to a projected adjusted EBITDA of $626.6 million, down from previous estimates of $664.6 million. Additionally, the persistent softness in volume is expected to negatively impact performance, contributing to a scenario where FY26 EBITDA may be 5% below current estimates, resulting in compression of the enterprise multiple to 5.0x, significantly lower than historical averages for acute care hospitals.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares